ANGLE plc (LON:AGL – Get Free Report)’s share price crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 2.35 and traded as low as GBX 2.33. ANGLE shares last traded at GBX 2.35, with a volume of 1,682,496 shares changing hands.
ANGLE Price Performance
The stock has a market capitalization of £7.58 million, a price-to-earnings ratio of -0.49 and a beta of 0.22. The company’s 50 day moving average is GBX 2.35 and its 200 day moving average is GBX 2.35. The company has a current ratio of 2.76, a quick ratio of 6.17 and a debt-to-equity ratio of 25.25.
ANGLE Company Profile
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD. ANGLE plc has a partnership agreement with Bio View Ltd to develop a liquid biopsy circulating tumor cell HER2 assay for breast cancer. The company was founded in 1994 and is based in Guildford, the United Kingdom.
Featured Articles
- Five stocks we like better than ANGLE
- 3 AI Infrastructure Stocks to Watch Beyond NVIDIA
- From SaaS-pocalypse to Perfect Storm: Workday’s AI Growth Story Strengthens
- These 3 GARP Stocks Show Why Growth and Value Do Not Have to Clash
- Venture Into High-Volatility Corners of the Market With These 3 ETFs
Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with MarketBeat.com's FREE daily email newsletter.
